Description:

SOUTHWEST ONCOLOGY GROUP S0221 AC or AC+G ADVERSE EVENT FORM Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E92CA885-2823-1D56-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E92CA885-2823-1D56-E034-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Breast Cancer NCT00070564 Toxicity - SOUTHWEST ONCOLOGY GROUP S0221 AC or AC+G ADVERSE EVENT FORM - 2264763v3.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP S0221 AC or AC+G ADVERSE EVENT FORM
    1. No Instruction available.
Header
Adverse Events
Select box if adverse events were assessed but not seen. (Otherwise complete information below.)
CTC Adverse Event Term
CTC Attribution Code
Comments

Similar models